Capforce Inc Asset Turnover Ratio (CFOR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Capforce Inc   (CFOR)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Capforce Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Capforce Inc asset turnover ratio, the ability of Capforce Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 1.72 in the second quarter (Jun 30 2026), CFOR's balance sheet remain strong.

Within sector Capforce Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition



CFOR Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change 576.73 % 302.77 % 290.92 % 136.93 % 381.42 %
Y / Y Revenue Change 1150 % - 424 % - 14185.71 %
Asset Turnover Ratio (TTM) 1.72 - 1.65 - 0.96
CFOR's Total Ranking # # # # #
Seq. Asset Change 137.3 % -1.58 % 201.09 % -3.76 % 41.23 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
P3 Health Partners Inc   2.25 $ 1,502.838  Millions$ 667.189  Millions
Vycor Medical Inc   2.10 $ 1.807  Millions$ 0.860  Millions
Iridex Corp  1.81 $ 51.044  Millions$ 28.259  Millions
Progyny Inc   1.78 $ 1,311.298  Millions$ 737.959  Millions
Chemed Corporation  1.65 $ 2,595.001  Millions$ 1,569.302  Millions
Aspira Women s Health inc   1.62 $ 9.029  Millions$ 5.569  Millions
Adm Tronics Unlimited Inc   1.59 $ 3.240  Millions$ 2.034  Millions
Lftd Partners Inc   1.56 $ 35.335  Millions$ 22.674  Millions
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Universal Health Services Inc   1.19 $ 18,646.705  Millions$ 15,622.036  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Mettler toledo International Inc   1.13 $ 4,133.875  Millions$ 3,643.493  Millions
Mimedx Group Inc   1.13 $ 354.086  Millions$ 312.829  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.